Hi-Tech Pharmaceuticals - Novedex XT - 60 Tablets

Novedex XT is a post-cycle therapy supplement from Hi-Tech Pharmaceuticals containing three steroidal aromatase inhibitors: Arimistane, androsta-1,4,6-triene-17-one, and androsta-4,6-diene-17-one, formulated to support estrogen management and testosterone balance after a prohormone cycle. Not appropriate for athletes subject to drug testing.

When you run a prohormone cycle, the body's hormonal environment shifts, and not just during the cycle. After you stop, the feedback mechanisms that regulate testosterone production may take time to normalize, often while estrogen levels are in flux. That window is what post-cycle therapy (PCT) is designed to address.

Novedex XT by Hi-Tech Pharmaceuticals is built specifically for that period. It contains three steroidal aromatase inhibitor compounds that act on the enzyme responsible for converting testosterone to estrogen, along with a bioavailability-focused delivery system designed to support absorption of fat-soluble active compounds.

Here's what's in the formula, how the mechanism works, and who this product is and isn't appropriate for.

What Is Novedex XT, and Who Is It For?

Novedex XT is a 60-tablet PCT formula designed for use in the weeks following a prohormone cycle. Its three active compounds are all aromatase inhibitors meaning they work by targeting the aromatase enzyme, which converts androgens (like testosterone) into estrogens (like estradiol).

By reducing aromatase activity post-cycle, the formula is designed to support the body's natural hormonal recovery: estrogen levels that climbed during the cycle are managed, and the testosterone-to-estrogen ratio is given support to move back toward baseline.

This is an advanced product. It is not designed for general wellness, hormone support in healthy adults who haven't run a prohormone cycle, or any use by women. The compounds in this formula exert real hormonal activity; this is not a herbal testosterone booster.

Quick Take: Who This Product Is Intended For

• Adult males completing a prohormone cycle seeking post-cycle support
• Users who understand the distinction between PCT and natural testosterone support
• Those working with a knowledgeable healthcare professional during or after hormonal supplementation
• Not appropriate for: women, anyone under 18, athletes subject to drug testing, or individuals with hormone-sensitive conditions

Understanding Aromatase: The Enzyme at the Center

Aromatase is a cytochrome P-450 enzyme complex that catalyzes the conversion of androgens, including testosterone and androstenedione, into estrogens, primarily estradiol. It is active in multiple tissues, including adipose (fat) tissue, liver, and muscle.

During a prohormone cycle, androgen levels rise significantly. The body responds in part by upregulating aromatase activity, accelerating the conversion of those androgens to estrogen. When the cycle ends and androgen input drops, that elevated aromatase activity can persist temporarily, which may lead to elevated estrogen alongside suppressed natural testosterone production.

This is the hormonal situation Novedex XT targets. Rather than providing androgens directly, its compounds work on the enzyme side: reducing the rate of conversion so that testosterone produced by the recovering HPG axis is less readily converted to estrogen.

The Three Active Compounds

Androsta-3,5-Diene-7,17-Dione (Arimistane)

Arimistane is the most widely recognized of the three compounds. It functions as a suicidal aromatase inhibitor, meaning it irreversibly binds to and permanently inactivates the aromatase enzyme rather than competing with it temporarily. Once bound, the enzyme is deactivated and must be replaced through new protein synthesis, thereby limiting the potential for estrogen rebound when the compound clears the system.

Beyond aromatase inhibition, Arimistane also inhibits cortisol, a catabolic hormone that rises during physiological stress, such as post-cycle hormonal fluctuations. Reducing cortisol support is proposed to help preserve lean mass during the recovery period.

Regulatory note: The FDA issued a warning letter in 2018 and a Scientific Memorandum in 2021 stating that Androsta-3,5-diene-7,17-dione does not meet the legal definition of a dietary ingredient under the FD&C Act. Users should be aware that this ingredient occupies a contested regulatory space. Consult current federal and state law applicable to your jurisdiction before purchasing.

3β-Hydroxy-androsta-1,4,6-triene-17-one

This compound (commonly referenced in the literature as ATD or its related forms) is a steroidal aromatase inhibitor that, like Arimistane, acts via irreversible binding. It has a strong affinity for the aromatase active site and has been studied in the context of both estrogen suppression and its effects on the testosterone-to-estrogen ratio in resistance-trained men.

An 8-week study published in the International Journal of Sport Nutrition and Exercise Metabolism (Willoughby & Wilborn, 2007) examined Novedex XT, then containing ATD as the primary active compound, in 16 young eugonadal men. The study observed average increases of 283% in total testosterone and 625% in free testosterone, along with a 3.5% reduction in fat mass, compared to placebo, with no significant changes in clinical safety markers during the study period.

This is a notable study, but important context applies: it was conducted in healthy eugonadal men (not post-cycle users), over 8 weeks, and the hormonal changes, while significant, were not evaluated for effects beyond that window.

WADA note: ATD and its structural relatives are prohibited under WADA S4 Hormone and Metabolic Modulators (aromatase inhibitors), both in-competition and out-of-competition. ATD metabolites have also been linked to false positives for boldenone, an anabolic steroid, in doping control urine tests.

3β-Hydroxy-androsta-4,6-diene-17-one

The third steroidal aromatase inhibitor in the blend, this compound adds a complementary binding profile to the formula. Like the other two, it targets aromatase to reduce estrogen synthesis. The inclusion of multiple inhibitors with slightly different structural characteristics is a design approach intended to provide broader aromatase coverage rather than relying on a single binding mechanism.

Quick Take: The Aromatase Inhibition Approach

• All three compounds are steroidal aromatase inhibitors working via irreversible (suicidal) binding
• Arimistane additionally targets cortisol, a catabolic hormone active post-cycle
• ATD was the subject of a published 8-week clinical study showing significant effects on the testosterone: estrogen ratio
• Multiple AI compounds included for complementary binding rather than single-mechanism reliance

The Bioavailability Delivery System

Steroidal compounds present a common challenge: they are highly fat-soluble, which means conventional tablet formulations may deliver inconsistent absorption depending on the presence or absence of dietary fat at the time of ingestion.

Novedex XT uses the same delivery technology seen in Hi-Tech's prohormone line: Phosphatidylcholine 75% and Hydroxypropyl Beta Cyclodextrin (HPBCD).

• Phosphatidylcholine encapsulates the active compounds in a phospholipid bilayer, mimicking the structure of cell membranes and facilitating absorption via intestinal lymphatic pathways, the same route used for dietary fats
• HPBCD (Hydroxypropyl Beta Cyclodextrin) is a cyclic oligosaccharide that forms inclusion complexes with the active compounds, improving their water solubility and stability in the GI tract without altering their chemical structure

The practical implication: the active compounds are less dependent on concurrent fat intake for adequate absorption. Medium-chain triglycerides (MCTs) are also included as a fat carrier to further support the lipid-based uptake pathway.

Phytosterols

Novedex XT includes phytosterols, plant-derived sterols structurally similar to cholesterol, as a supporting ingredient. Phytosterols are commonly used in the delivery matrix of lipid-soluble compounds, and some research suggests they may offer additional roles in supporting hormonal substrate availability.

Quick Take: What the Delivery System Does

• Phosphatidylcholine wraps active compounds in a lipid bilayer for lymphatic absorption
• HPBCD improves the water solubility and GI stability of the steroidal compounds
• MCTs provide a fat carrier to support the lipid-uptake pathway
• Combined effect: more consistent bioavailability regardless of whether the tablet is taken with food

How to Take Novedex XT?

Take 1 tablet daily, preferably in the evening, for the duration of your PCT period, typically 4-6 weeks following a prohormone cycle. Some protocols use up to 2 tablets per day (1 morning, 1 afternoon); do not exceed the dosage recommended on the label.

For standalone use (not following a prohormone cycle), the product is not intended for continuous long-term use. A cycle of 60 days on followed by a 60-day off period is a commonly referenced protocol.

Do not stack with other aromatase inhibitors or estrogen-control products unless directed by a healthcare provider. Excessive aromatase suppression can lead to estrogen levels dropping too low, which carries its own consequences, including joint discomfort, reduced libido, and potential negative effects on cardiovascular and bone health.

Who Should Not Use Novedex XT?

This product is not appropriate for:

• Women - aromatase inhibitors have significant hormonal effects in women, including effects on bone density and reproductive hormones
• Anyone under 18 years of age
• Competitive athletes subject to drug testing - all three active compounds are prohibited by WADA under S4, and ATD may produce false positives for boldenone
• Anyone with hormone-sensitive conditions - including prostate conditions, cardiovascular disease, or clotting disorders
• Anyone taking prescription medications - particularly medications that interact with CYP450 pathways or hormone-related drugs
• Anyone who has not run a prohormone cycle - this is a targeted recovery compound, not a general testosterone support supplement

If you have any health conditions or take any medications, consult your healthcare provider before use. Post-cycle hormonal management has real physiological consequences; this is not a category where guesswork is appropriate.

Frequently Asked Questions

1. What is Novedex XT used for?

Novedex XT is designed for use as post-cycle therapy following a prohormone cycle. Its three active compounds are steroidal aromatase inhibitors; they work by blocking the enzyme that converts testosterone into estrogen. During and after a prohormone cycle, estrogen levels can rise, and natural testosterone production can be suppressed; Novedex XT is formulated to support the body's return toward its pre-cycle hormonal state during the recovery window.

2. How does an aromatase inhibitor differ from a testosterone booster?

A testosterone booster typically works by providing precursors or plant extracts that support the body's own testosterone production, through ingredients like tribulus, fenugreek, ashwagandha, or zinc. An aromatase inhibitor like Novedex XT works on the conversion side: it reduces the rate at which testosterone (and other androgens) are converted to estrogen by inhibiting the aromatase enzyme. The two approaches can complement each other, but they target different parts of the hormonal equation.

3. Is Novedex XT safe to use on its own without a prohormone cycle?

While some users take aromatase inhibitors as standalone testosterone support, Novedex XT is specifically formulated and positioned for post-cycle use. The compounds are hormonally active, and using aromatase inhibitors without a clinical reason to suppress estrogen, particularly in healthy eugonadal men, carries the risk of driving estrogen too low. Low estrogen in men is associated with joint discomfort, mood changes, cardiovascular strain, and bone density loss. If you are not post-cycle and are looking for general testosterone support, a natural testosterone booster may be more appropriate. Consult a healthcare provider before use.

4. Is Novedex XT banned in sports?

Yes. All three active compounds in Novedex XT are prohibited by WADA under S4 Hormone and Metabolic Modulators (specifically, aromatase inhibitors), which applies both in-competition and out-of-competition. One of the compounds, ATD, has also been documented to produce false positives for the anabolic steroid boldenone in doping control tests. Any athlete subject to drug testing, including at national, collegiate, or military levels, should not use this product.

5. What is the clinical research behind Novedex XT?

An 8-week study published in the International Journal of Sport Nutrition and Exercise Metabolism (Willoughby & Wilborn, 2007) examined the effects of Novedex XT in 16 young, hormonally normal men. The study observed average increases of 283% in total testosterone and 625% in free testosterone compared to placebo, along with a 3.5% decrease in fat mass. No significant changes in clinical safety markers were noted during the study. It's worth noting that this study used healthy men who were not post-cycle, so effects in post-cycle users, the primary target audience, may differ. Individual results vary, and this data should not be treated as guaranteed outcomes.

6. How long should I run Novedex XT for PCT?

Most PCT protocols using aromatase inhibitors run for 4-6 weeks after a prohormone cycle. Novedex XT's packaging suggests 1 tablet daily, and the 60-tablet count supports a 60-day run for standalone use or a full post-cycle protocol. Do not run aromatase inhibitor-based PCT indefinitely once your hormone levels have normalized, continued suppression of estrogen can be counterproductive. Working with a healthcare professional to monitor your hormone levels during and after PCT is strongly encouraged.

7. Can women use Novedex XT?

No. Aromatase inhibitors have significant hormonal consequences in women including effects on estrogen-dependent bone mineral density, reproductive function, and cardiovascular health. Pharmaceutical aromatase inhibitors are used in women only under close medical supervision for specific medical indications (such as hormone-receptor-positive breast cancer). This product is designed for adult men only and should not be used by women under any circumstances.

8. What is Arimistane and why is it in Novedex XT?

Arimistane (Androsta-3,5-diene-7,17-dione) is a well-known suicidal aromatase inhibitor included in many PCT-oriented products. It permanently inactivates the aromatase enzyme upon binding, which reduces the potential for estrogen to rebound when the compound clears. It also has proposed cortisol-inhibiting properties, which may support lean mass retention during the post-cycle period. Be aware that the FDA has classified Arimistane as a compound that does not meet the legal definition of a dietary supplement ingredient users should verify current applicable regulations in their jurisdiction before purchasing.

9. Can I stack Novedex XT with other PCT products?

Stacking multiple aromatase inhibitors is generally not recommended without medical oversight, as it increases the risk of over-suppressing estrogen. However, Novedex XT may be combined with non-AI PCT support compounds such as natural testosterone support ingredients as part of a broader recovery protocol. Do not combine with other products containing Arimistane or steroidal aromatase inhibitors. If you are planning a multi-compound PCT, consult a healthcare professional familiar with hormonal supplementation before stacking.

10. How quickly will I notice effects from Novedex XT?

Aromatase inhibitors can begin affecting circulating hormone levels relatively quickly reductions in estrogen can occur within the first week as the compounds inhibit the conversion enzyme. The downstream effects on testosterone levels may take several weeks to become meaningful, as HPG axis recovery involves a cascade of hormonal signals rather than a single switch. Some users report noticing changes in mood, energy, and libido within the first 1-2 weeks, though individual response varies significantly depending on what was cycled, cycle length, and individual hormonal recovery rate.

Conclusion

Novedex XT is a targeted tool for a specific purpose: managing the hormonal transition at the end of a prohormone cycle. Its three steroidal aromatase inhibitors work through irreversible enzyme binding rather than temporary competition, supported by a lipid-based delivery system designed to make the fat-soluble active compounds more consistently bioavailable. This is a product for experienced users who understand what they're using it for and why, not a general testosterone support option. Athletes subject to drug testing should not use this product, as all active compounds are prohibited by WADA. Consult a qualified healthcare provider before beginning any PCT protocol.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.